Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study
Submitted by mike kraft on
..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.